Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche
Pharma
Roche's bispecific Lunsumio goes subcutaneous
The new under-the-skin formulation reduces the Lunsumio administration time to about one minute compared with two to four hours for an infusion.
Angus Liu
Dec 22, 2025 10:15am
FDA approves AZ/Daiichi's Enhertu in 1st-line breast cancer
Dec 15, 2025 4:15pm
Lilly shifts oral SERD hopes to its largest oncology trial ever
Dec 12, 2025 11:45am
ASH: Regeneron eyes simpler regimens to grow bispecifics' reach
Dec 8, 2025 8:00am
Regeneron wins 2 Eylea nods, ramping up competition with Roche
Nov 20, 2025 11:53am
Trump's Swiss trade deal caps pharma tariffs at 15%
Nov 17, 2025 10:30am
